A detailed history of Boston Common Asset Management, LLC transactions in Novozymes A/S Sponsored Adr (D stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 4,119 shares of NVZMY stock, worth $240,467. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,119
Previous 4,613 10.71%
Holding current value
$240,467
Previous $282,000 5.32%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$60.61 - $72.03 $29,941 - $35,582
-494 Reduced 10.71%
4,119 $297,000
Q2 2024

Jul 08, 2024

SELL
$54.21 - $63.59 $40,169 - $47,120
-741 Reduced 13.84%
4,613 $282,000
Q1 2024

Apr 11, 2024

SELL
$50.49 - $61.73 $5,452 - $6,666
-108 Reduced 1.98%
5,354 $314,000
Q4 2023

Jan 09, 2024

SELL
$38.77 - $55.49 $512,965 - $734,188
-13,231 Reduced 70.78%
5,462 $300,000
Q3 2023

Oct 11, 2023

BUY
$39.7 - $50.74 $7,662 - $9,792
193 Added 1.04%
18,693 $756,000
Q2 2023

Jul 24, 2023

SELL
$46.04 - $54.69 $11,279 - $13,399
-245 Reduced 1.31%
18,500 $862,000
Q1 2023

May 17, 2023

BUY
$47.3 - $52.94 $15,703 - $17,576
332 Added 1.8%
18,745 $959,000
Q4 2022

Jan 26, 2023

BUY
$47.06 - $60.8 $46,965 - $60,678
998 Added 5.73%
18,413 $930,000
Q3 2022

Oct 20, 2022

SELL
$48.38 - $63.99 $32,511 - $43,001
-672 Reduced 3.72%
17,415 $879,000
Q2 2022

Aug 10, 2022

BUY
$55.8 - $70.04 $490,147 - $615,231
8,784 Added 94.42%
18,087 $1.08 Million
Q1 2022

May 16, 2022

SELL
$57.93 - $81.66 $61,869 - $87,212
-1,068 Reduced 10.3%
9,303 $0
Q4 2021

Jan 31, 2022

BUY
$66.41 - $83.12 $41,439 - $51,866
624 Added 6.4%
10,371 $0
Q3 2021

Nov 12, 2021

BUY
$68.4 - $80.96 $39,672 - $46,956
580 Added 6.33%
9,747 $668,000
Q2 2021

Aug 19, 2021

BUY
$62.84 - $75.74 $85,211 - $102,703
1,356 Added 17.36%
9,167 $0
Q1 2021

May 14, 2021

BUY
$56.41 - $66.23 $160,260 - $188,159
2,841 Added 57.16%
7,811 $0
Q4 2020

Feb 05, 2021

BUY
$54.99 - $65.67 $42,067 - $50,237
765 Added 18.19%
4,970 $286,000
Q3 2020

Nov 10, 2020

SELL
$57.4 - $65.98 $2,410 - $2,771
-42 Reduced 0.99%
4,205 $265,000
Q2 2020

Aug 10, 2020

BUY
$44.77 - $58.07 $190,138 - $246,623
4,247 New
4,247 $245,000
Q4 2019

Jan 28, 2020

SELL
$40.36 - $49.32 $861,040 - $1.05 Million
-21,334 Closed
0 $0
Q3 2019

Nov 07, 2019

SELL
$42.06 - $44.29 $136,400 - $143,632
-3,243 Reduced 13.2%
21,334 $897,000
Q2 2019

Jul 26, 2019

SELL
N/A
-1,608 Reduced 6.14%
24,577 $1.15 Million
Q1 2019

May 03, 2019

BUY
N/A
3,618 Added 16.03%
26,185 $1.21 Million
Q4 2018

Jan 25, 2019

BUY
N/A
3,911 Added 20.96%
22,567 $1.01 Million
Q3 2018

Nov 01, 2018

BUY
N/A
1,014 Added 5.75%
18,656 $1.03 Million
Q2 2018

Aug 06, 2018

SELL
N/A
-4,640 Reduced 20.82%
17,642 $895,000
Q1 2018

Apr 26, 2018

BUY
N/A
2,139 Added 10.62%
22,282 $1.15 Million
Q4 2017

Feb 07, 2018

SELL
N/A
-2,151 Reduced 9.65%
20,143 $1.15 Million
Q3 2017

Nov 13, 2017

SELL
N/A
-9 Reduced 0.04%
22,294 $1.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
22,303
22,303 $975,000

Others Institutions Holding NVZMY

About NOVOZYMES A/S SPONSORED ADR (D


  • Ticker NVZMY
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 276,303,008
  • Market Cap $16.1B
More about NVZMY
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.